Addition of Muramyl Tripeptide to Chemotherapy for Patients with Newly Diagnosed Metastatic Osteosarcoma: a Report from the Children's Oncology Group

BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (L-MTPPE) to chemotherapy has been shown to improve overall survival in patients with non-metastatic osteosarcoma (OS). We report the results of L-MTP-PE addition to chemotherapy for patients with metastatic OS. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chou, Alexander J., Kleinerman, Eugenie S., Krailo, Mark D., Chen, Zhengjia, Betcher, Donna L., Healey, John H., Conrad, Ernest U., Nieder, Michael L., Weiner, Michael A., Wells, Robert J., Womer, Richard B., Meyers, Paul A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783515/
https://ncbi.nlm.nih.gov/pubmed/19637348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24566
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados